English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Horizon Pharma
Robert Hadley
| Jun 17, 2017
U.S. court sides with Horizon Pharma in patent infringement claim regarding Pennsaid
Chandra Lye
| May 4, 2017
FDA approves use of Ravicti to treat urea cycle disorders in younger pediatric patients
Ruth de Jauregui
| Mar 31, 2017
Horizon Pharma presents new data on Ravicti
Gene Johnson
| Mar 24, 2017
Horizon Pharma launches initiative for people with rare genetic disease
Jireh Gibson
| Mar 19, 2017
Horizon Pharma launches initiative to raise awareness of people affected by rare diseases
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
